デフォルト表紙
市場調査レポート
商品コード
1466219

ヒトマイクロバイオーム市場:疾患別、技術別、製品別、治療領域別、用途別-2024-2030年の世界予測

Human Microbiome Market by Disease (Acute Diarrhea, Autoimmune Disorders, Cancer), Technology (16s rRNA Sequencing, Cell Culture Technology, Computational Tools), Product, Therapeutic Area, Application - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 198 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.74円
ヒトマイクロバイオーム市場:疾患別、技術別、製品別、治療領域別、用途別-2024-2030年の世界予測
出版日: 2024年04月17日
発行: 360iResearch
ページ情報: 英文 198 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヒトマイクロバイオーム市場規模は2023年に15億8,000万米ドルと推計され、2024年には19億6,000万米ドルに達し、CAGR 23.90%で2030年には71億1,000万米ドルに達すると予測されています。

ヒトマイクロバイオームは、人体上および体内に存在する微生物のゲノムの集合体です。これには細菌、古細菌、ウイルス、真核微生物が含まれます。人体には、これらの微生物細胞が何兆個も存在し、身体機能や健康に影響を与えます。食物の消化、病原体からの保護、免疫系の発達を助ける。一方、慢性疾患の有病率が上昇し、マイクロバイオームと様々な健康状態を関連付ける調査の必要性が高まっていることが、マイクロバイオームに基づく診断薬や治療薬の需要をさらに押し上げています。栄養学におけるマイクロバイオームへのニーズの高まりは、全体的なウェルネスと免疫機能をサポートし、影響を与えるヒトマイクロバイオームの需要を後押ししています。しかし、生きたバイオ治療製品の承認に関連する規制上のハードルや、マイクロバイオームを理解し操作することの複雑さは、主要プレーヤーにとって大きな課題となっています。企業は事業成長を最適化するために、研究開発(R&D)活動と費用対効果が高く利用しやすいシーケンス技術に継続的に注力しています。さらに、新規治療薬の開発における主な発展と投資の増加は、世界の領域で事業を展開する主要企業に大きな機会をもたらしています。人工知能(AI)や高度な機械学習(ML)などの開発主技術は、複雑な微生物相互作用をよりよく理解し、新規治療ソリューションを開発するためにマイクロバイオーム研究と統合されています。

主な市場の統計
基準年[2023] 15億8,000万米ドル
予測年[2024] 19億6,000万米ドル
予測年 [2030] 71億1,000万米ドル
CAGR(%) 23.90%

テクノロジー16s rRNAシーケンシングとオミックス技術の最近の進歩により、人体の分子因子とプロセスが調査可能に

16sリボソームRNAシーケンシングは、サンプル内の細菌を同定し比較するために広く使用されている手法です。原核生物のリボソームの30S小サブユニットの構成要素である16S rRNA遺伝子に着目したもので、細菌や古細菌の異なる種間で高度に保存されています。この技術は、研究者が細菌を分類し、系統を決定するのに役立ち、マイクロバイオームの構成に関する洞察を提供します。一方、細胞培養技術では、管理された条件下、通常は自然環境外で細胞を培養します。マイクロバイオーム研究では、細胞培養技術によって、研究用の微生物を分離・維持することができます。次世代シーケンサー(NGS)を含むハイスループット技術は、微生物群集を研究するスピードと規模に革命をもたらしました。これらの手法では、何百万ものDNA分子の同時シーケンスが可能であり、マイクロバイオームの多様性と機能を包括的に把握することができます。さらに、メタゲノム解析は環境サンプルから得られた遺伝物質を解析するため、研究者は実験室で生物を培養する必要がなくなります。この技術は、試験管内で培養することが容易でないものも含め、存在するすべての微生物の遺伝物質を培養に依存せずに調べることができるため、ヒトマイクロバイオームの研究に役立ちます。さらに、ゲノミクス、トランスクリプトミクス、プロテオミクス、メタボロミクスなどのオミクス技術は、生物学的システムの全体像と高解像度の洞察を提供します。マイクロバイオーム研究において、これらの技術は、微生物群集のゲノムRNA転写物、プロテオミクス、代謝産物など、様々な分子因子やプロセスを調査します。

応用様々な健康状態に対応するヘルスケア診断と治療におけるヒトマイクロバイオームの採用拡大

ヒトマイクロバイオームは、人体内および人体上に存在する微生物のゲノムの集合体であり、診断におけるその可能性がますます注目される分野となっています。次世代シーケンサーとバイオインフォマティクスの進歩により、研究者は特定の微生物組成と活性を様々な健康状態と関連付けることができるようになった。診断分野では、ヒトマイクロバイオームを解析することで、炎症性腸疾患、糖尿病、ある種のがんなどの疾患のバイオマーカーの同定が容易になります。治療領域では、ヒトマイクロバイオームは微生物叢に基づく治療による個別化医療の可能性を提供します。糞便微生物叢移植(FMT)は、健康的な微生物バランスを回復させることでクロストリジウム・ディフィシル感染症の治療に用いられます。

地域別インサイト

南北アメリカでは、米国とカナダが先進マイクロバイオームの研究開発と商業化に牽引されてヒトマイクロバイオームで大きな成長を遂げ、多くの企業がマイクロバイオームに基づく治療法や診断法の開発に積極的に取り組んでいます。この地域のヒトマイクロバイオームの状況は着実に成長しており、マイクロバイオームがヒトの健康や疾病に与える影響を理解することを目的とした研究が中心となっています。一方、欧州諸国はマイクロバイオーム研究に対する政府の強力な支援を示しており、数多くのイニシアチブと研究コンソーシアムが設立されています。欧州における規制の枠組みは、マイクロバイオームのデータや製品の安全かつ倫理的な利用を支援するために発展しつつあります。中東・アフリカ地域は、主に生活習慣病の増加やヘルスケア支出の増加を背景に、ヒトマイクロバイオーム製品の成長市場となっています。同時に、アジア太平洋地域のヒトマイクロバイオーム市場は、健康全般における微生物バランスの重要性に対する意識の高まり、医療費の増加、微生物ゲノミクスの進歩により、大きな成長を遂げています。プロバイオティクス、プレバイオティクス、シンバイオティクスの研究開発は、特に胃腸障害や慢性疾患といった地域の健康問題に対処するために、この地域で成長しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、ヒトマイクロバイオーム市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、ヒトマイクロバイオーム市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています:

1.ヒトマイクロバイオーム市場の市場規模および予測は?

2.ヒトマイクロバイオーム市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か?

3.ヒトマイクロバイオーム市場の技術動向と規制枠組みは?

4.ヒトマイクロバイオーム市場における主要ベンダーの市場シェアは?

5.ヒトマイクロバイオーム市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • ヒトマイクロバイオーム療法の開発への重点化
      • 創薬、早期疾患検出、診断のためのヒトマイクロバイオーム
      • プロバイオティクスと乳児栄養におけるマイクロバイオームの需要増加
    • 抑制要因
      • マイクロバイオーム治療に関する専門知識の不足と安全性の問題
    • 機会
      • 成長機会を創出するためのコラボレーションと調査投資の増加
      • 新規治療薬の開発
    • 課題
      • 細菌種の数の理解における限界とヒトマイクロバイオームに基づく医薬品の不確実性
  • 市場セグメンテーション分析
    • テクノロジー:人体の分子因子とプロセスを調査するための16s rRNAシーケンシングとオミックス技術の最近の進歩
    • 応用:さまざまな健康状態に対応するために、ヘルスケア診断および治療におけるヒトマイクロバイオームの採用が増加しています。
  • 市場動向分析
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制枠組みの分析
  • 顧客のカスタマイズ
    • 知的財産の情勢

第6章 ヒトマイクロバイオーム市場:疾患別

  • 急性下痢
  • 自己免疫疾患
  • がん
  • 糖尿病
  • 精神障害
  • 肥満

第7章 ヒトマイクロバイオーム市場:技術別

  • 16s rRNAシーケンシング
  • 細胞培養技術
  • 計算ツール
  • 高スループット技術
  • メタゲノムシーケンシング
  • オミックス技術

第8章 ヒトマイクロバイオーム市場:製品別

  • 診断装置
  • 薬物
  • 食品
  • プレバイオティクスとプロバイオティクス

第9章 ヒトマイクロバイオーム市場治療領域別

  • 胃腸障害
  • 代謝障害
  • 皮膚疾患
  • 女性の健康

第10章 ヒトマイクロバイオーム市場:用途別

  • 診断
  • 治療薬

第11章 南北アメリカのヒトマイクロバイオーム市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第12章 アジア太平洋地域のヒトマイクロバイオーム市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第13章 欧州・中東・アフリカのヒトマイクロバイオーム市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第14章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス、2023
  • 競合シナリオ分析
    • Clinical MicrobiomicsがCosmosIDとの合併を発表
    • ネスレ、健康とウェルビーイング製品でAPC Microbiomeと提携
    • UWメディシンがマイクロバイオーム研究のための新センターを設立

第15章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. HUMAN MICROBIOME MARKET RESEARCH PROCESS
  • FIGURE 2. HUMAN MICROBIOME MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. HUMAN MICROBIOME MARKET DYNAMICS
  • FIGURE 7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. HUMAN MICROBIOME MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. HUMAN MICROBIOME MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HUMAN MICROBIOME MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN'S HEALTH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN'S HEALTH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 138. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 140. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 142. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. CHINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 148. CHINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 149. CHINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 150. CHINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 151. CHINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 152. CHINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 153. CHINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 154. CHINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 155. CHINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. CHINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. INDIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 158. INDIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 159. INDIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 160. INDIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 161. INDIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 162. INDIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 163. INDIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 164. INDIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 165. INDIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 166. INDIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 167. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 168. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 169. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 170. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 171. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 172. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 173. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 174. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 175. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. JAPAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 178. JAPAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 179. JAPAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 180. JAPAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 181. JAPAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 182. JAPAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 183. JAPAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 184. JAPAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 185. JAPAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. JAPAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 188. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 189. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 190. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 191. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 192. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 193. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 194. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 195. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 198. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 200. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 202. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 203. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 204. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 205. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 208. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 209. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 210. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 211. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 212. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 213. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 214. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 215. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 218. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 220. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 222. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 224. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 225. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 228. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 229. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 230. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 231. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 232. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 233. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 234. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 235. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. THAILAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 238. THAILAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 239. THAILAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 240. THAILAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 241. THAILAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 242. THAILAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 243. THAILAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 244. THAILAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 245. THAILAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. THAILAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 248. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 249. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 250. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 251. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 252. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 253. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 254. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 255. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 256. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 269. DENMARK HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 270. DENMARK HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 271. DENMARK HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 272. DENMARK HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 273. DENMARK HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 274. DENMARK HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 275. DENMARK HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 276. DENMARK HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 277. DENMARK HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. DENMARK HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. EGYPT HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 280. EGYPT HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 281. EGYPT HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 282. EGYPT HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 283. EGYPT HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 284. EGYPT HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 285. EGYPT HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 286. EGYPT HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 287. EGYPT HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 288. EGYPT HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 289. FINLAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 290. FINLAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 291. FINLAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 292. FINLAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 293. FINLAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 294. FINLAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 295. FINLAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 296. FINLAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 297. FINLAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 298. FINLAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 299. FRANCE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 300. FRANCE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 301. FRANCE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 302. FRANCE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 303. FRANCE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 304. FRANCE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 305. FRANCE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 306. FRANCE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 307. FRANCE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 308. FRANCE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 309. GERMANY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 310. GERMANY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 311. GERMANY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 312. GERMANY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 313. GERMANY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 314. GERMANY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 315. GERMANY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 316. GERMANY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 317. GERMANY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 318. GERMANY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 319. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 320. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 321. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 322. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 323. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 324. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 325. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 326. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 327. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 328. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 329. ITALY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 330. ITALY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 331. ITALY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 332. ITALY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 333. ITALY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 334. ITALY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 335. ITALY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 336. ITALY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 337. ITALY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 338. ITALY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 339. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 340. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 341. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 342. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 343. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 344. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 345. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 346. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 347. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 348. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 349. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 350. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 351. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 352. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 353. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 354. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 355. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 356. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 357. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 358. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 359. NORWAY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 360. NORWAY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 361. NORWAY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 362. NORWAY HUMAN MICROBIOME MARKET SIZE, BY TEC
目次
Product Code: MRR-430D42AA0FCD

[198 Pages Report] The Human Microbiome Market size was estimated at USD 1.58 billion in 2023 and expected to reach USD 1.96 billion in 2024, at a CAGR 23.90% to reach USD 7.11 billion by 2030.

The human microbiome is the collective genomes of the microorganisms that reside on and inside the human body. These include bacteria, archaea, viruses, and eukaryotic microbes. The human body hosts trillions of these microbial cells, which can influence bodily functions and health. It assists in the digestion of food, protection against pathogens, and the development of the immune system. Meanwhile, the rise in chronic disease prevalence and a growing need for research linking the microbiome to various health conditions further stokes demand for microbiome-based diagnostics and therapeutics. The growing need for a microbiome in nutrition propels the demand for a human microbiome to support and influence overall wellness and immune function. However, the regulatory hurdles associated with approving live biotherapeutic products and complexities in comprehending and manipulating the microbiome present a significant challenge for the key players. Companies are continuously focusing on research and development (R&D) activities and cost-effective and accessible sequencing technologies to optimize their business growth. Moreover, the advancements in developing novel human microbiome therapeutics and rising investments present a significant opportunity for the key companies operating in the global space. Emerging technologies such as artificial intelligence (AI) and advanced machine learning (ML) are integrated with microbiome research to understand complex microbial interactions better and develop novel therapeutic solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 1.58 billion
Estimated Year [2024] USD 1.96 billion
Forecast Year [2030] USD 7.11 billion
CAGR (%) 23.90%

Technology: Recent advancements in 16s rRNA sequencing and omics technology to investigate molecular factors and processes in human body

16s ribosomal RNA sequencing is a widely used method for identifying and comparing bacteria within a sample. It focuses on the 16S rRNA gene, a component of the 30S small subunit of prokaryotic ribosomes, which is highly conserved within different species of bacteria and archaea. This technique helps researchers classify and determine the phylogeny of bacteria, providing insights into the microbiome's composition. On the other hand, cell culture technology involves growing cells under controlled conditions, typically outside their natural environment. In microbiome research, cell culture technology allows scientists to isolate and maintain microorganisms for study. High-throughput technologies, including next-generation sequencing (NGS), have revolutionized the speed and scale at which microbial communities can be studied. These methods allow for the simultaneous sequencing of millions of DNA molecules, offering a comprehensive view of the microbiome's diversity and function. Moreover, metagenomic sequencing analyzes the genetic material obtained from environmental samples, helping researchers bypass the need to cultivate organisms in the lab. This technology helps study the human microbiome by allowing for a culture-independent examination of the genetic material of all microorganisms present, including those not easily cultured in vitro. Furthermore, omics technologies, such as genomics, transcriptomics, proteomics, and metabolomics, provide holistic views and high-resolution insights into biological systems. In microbiome research, these technologies investigate various molecular factors and processes, such as the genomics RNA transcripts, proteomics, and metabolites of microbial communities.

Application: The increasing adoption of the human microbiome in healthcare diagnostics and therapeutics to cater to various health conditions

The human microbiome, comprised of the collective genome of microorganisms residing in and on the human body, has become an area of increasing interest for its potential in diagnostics. Advancements in next-generation sequencing and bioinformatics have allowed researchers to correlate specific microbial compositions and activities with various health conditions. For diagnostics, analysis of the human microbiome facilitates the identification of biomarkers for diseases such as inflammatory bowel disease, diabetes, and certain types of cancer. In the therapeutic domain, the human microbiome offers the potential for personalized medicine through microbiota-based treatments. Fecal microbiota transplantation (FMT) is used to treat clostridium difficile infections by restoring a healthy microbial balance.

Regional Insights

In the Americas, the United States and Canada witnessed significant growth in human microbiome driven by the research and commercialization of advanced microbiome, with numerous companies actively engaged in developing microbiome-based therapies and diagnostics. The human microbiome landscape in this region is steadily growing, focusing on research aimed at understanding the impact of the microbiome on human health and disease. On the other hand, European countries exhibit strong government support for microbiome research with numerous initiatives and research consortia in place. The regulatory framework in Europe is evolving to support the safe and ethical use of microbiome data and products. The Middle East and Africa region represents a growing market for human microbiome products, primarily driven by an increasing burden of lifestyle diseases and growing healthcare expenditure. At the same time, the human microbiome landscape in the Asia-Pacific region is experiencing significant growth, driven by increasing awareness of the importance of microbial balance to overall health, rising healthcare expenditures, and advancements in microbial genomics. Research and development in probiotics, prebiotics, and symbiotics are growing in this region, particularly in addressing regional health issues such as gastrointestinal disorders and chronic diseases.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Human Microbiome Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Human Microbiome Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Human Microbiome Market, highlighting leading vendors and their innovative profiles. These include AOBiome, LLC, Astarte Medical Partners, Inc, Axial Therapeutics, Inc., Azitra, BiomeSense, Inc., BiomX Ltd., DuPont de Nemours, Inc., Enterome Bioscience, Evelo Biosciences, Inc., Exeliom Biosciences SAS, Ferring B.V., Finch Therapeutics Group, Inc., Illumina, Inc., Intralytix, Inc., Invivo Healthcare, Locus Biosciences, Inc., Merck KGaA, Metabiomics Corporation, Osel Inc., Rebiotix Inc., Second Genome, Inc., Seres Therapeutics, Inc., Synlogic, Inc., Theriva Biologics, Inc., Vedanta Biosciences, Inc., Viome Life Sciences, Inc., and Yakult Honsha Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Human Microbiome Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Disease
    • Acute Diarrhea
    • Autoimmune Disorders
    • Cancer
    • Diabetes
    • Mental Disorders
    • Obesity
  • Technology
    • 16s rRNA Sequencing
    • Cell Culture Technology
    • Computational Tools
    • High-Throughput Technology
    • Metagenomic Sequencing
    • Omics Technology
  • Product
    • Diagnostic Devices
    • Drugs
    • Foods
    • Prebiotic & Probiotics
  • Therapeutic Area
    • Gastrointestinal Disorders
    • Metabolic Disorders
    • Skin Disorders
    • Women's Health
  • Application
    • Diagnostics
    • Therapeutics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Human Microbiome Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Human Microbiome Market?

3. What are the technology trends and regulatory frameworks in the Human Microbiome Market?

4. What is the market share of the leading vendors in the Human Microbiome Market?

5. Which modes and strategic moves are suitable for entering the Human Microbiome Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased Focus on Development of Human Microbiome Therapy
      • 5.1.1.2. Human Microbiome for Drug Discovery, Early Disease Detection, and Diagnosis
      • 5.1.1.3. Increasing Demand for Microbiome in Probiotics and Infant Nutrition
    • 5.1.2. Restraints
      • 5.1.2.1. Limited Expertise and Safety Issue related to Microbiome Therapeutics
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing Collaborations and Research Investments to Create Growth Opportunities
      • 5.1.3.2. Development of Novel Human Microbiome Therapeutic Products
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations in Understanding Number of Bacterial Species and Uncertainty of Human Microbiome-Based Drugs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Recent advancements in 16s rRNA sequencing and omics technology to investigate molecular factors and processes in human body
    • 5.2.2. Application: The increasing adoption of the human microbiome in healthcare diagnostics and therapeutics to cater to various health conditions
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization
    • 5.9.1. Intellectual Property Landscape

6. Human Microbiome Market, by Disease

  • 6.1. Introduction
  • 6.2. Acute Diarrhea
  • 6.3. Autoimmune Disorders
  • 6.4. Cancer
  • 6.5. Diabetes
  • 6.6. Mental Disorders
  • 6.7. Obesity

7. Human Microbiome Market, by Technology

  • 7.1. Introduction
  • 7.2. 16s rRNA Sequencing
  • 7.3. Cell Culture Technology
  • 7.4. Computational Tools
  • 7.5. High-Throughput Technology
  • 7.6. Metagenomic Sequencing
  • 7.7. Omics Technology

8. Human Microbiome Market, by Product

  • 8.1. Introduction
  • 8.2. Diagnostic Devices
  • 8.3. Drugs
  • 8.4. Foods
  • 8.5. Prebiotic & Probiotics

9. Human Microbiome Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Gastrointestinal Disorders
  • 9.3. Metabolic Disorders
  • 9.4. Skin Disorders
  • 9.5. Women's Health

10. Human Microbiome Market, by Application

  • 10.1. Introduction
  • 10.2. Diagnostics
  • 10.3. Therapeutics

11. Americas Human Microbiome Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Human Microbiome Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Human Microbiome Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Clinical Microbiomics Announces Merger with CosmosID
    • 14.3.2. Nestle Partners APC Microbiome on Health and Wellbeing Products
    • 14.3.3. UW Medicine Launches a New Center to Study Microbiomes

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio